Tag: Chemotherapy
Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
In phase 2 trial, longer progression-free survival for elotuzumab with pomalidomide and dexamethasone
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease
CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity
Incidence of congestive heart failure at 31 percent among women with a history of cardiotoxicity
Cardiac Monitoring Needed for High-Risk Breast Cancer Patients
Trastuzumab, certain chemo treatments increase patient risk of heart failure
Pembrolizumab Not Better Than PTX for Advanced Gastric Cancer
Survival no better with second-line pembrolizumab than paclitaxel for gastric, gastro-esophageal cancer
ASCO: Overall Survival Up for African-American Men With mCRPC
Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen
ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
Worse Survival for BRCA Germline Mutation Carriers in Pancreatic CA
For BRCA germline mutation carriers, better survival seen with platinum-based chemotherapy
ICU Mortality Similar for Patients With Hematologic CA ± Chemo
However, patients with hematologic cancer receiving chemotherapy have longer ICU, hospital stays
Peripheral Neuropathy Common in Childhood Cancer Survivors
Long-term neurotoxicity was more frequently seen with cisplatin than with vinca alkaloids
